In the first segment, Dr. Matthew Barrett talks with Dr. Simone Baiardi about using real-time quaking-induced conversion (RT-QuIC) to identify patients with Lewy body disease. In the second part of the podcast, Dr. Jeff Ratliff discusses the association of central hypersomnia and fatigue in multiple sclerosis with Dr. Anne-Laure Dubessy.

In the first segment, Dr. Stacey Clardy talks with Dr. Daniel Hartung about whether closing the Part D coverage gap between 2010-2019 lowered patients’ out-of-pocket costs for multiple sclerosis drugs. In the second part of the podcast, Dr. Teshamae Monteith discusses sex, exercise, and other benign causes of thunderclap headache with Dr. Jonathan Smith in the final part of our four-part series on thunderclap headache.

In the first segment, Dr. Jason Crowell talks with Dr. Paul Ford about patient perceptions of the FDA approval process for disease modifying therapies in people living with multiple sclerosis. In the second part of the podcast, Dr. Teshamae Monteith discusses the management of cerebral aneurysm with Dr. Dileep Yavagal in the third part of our four-part series on thunderclap headache.

In the first segment, Dr. Halley Alexander talks with Dr. Pia De Stefano about the safety and efficacy of artificial coma induction in the treatment of status epilepticus. In the second part of the podcast, Dr. Teshamae Monteith discusses a case presentation of RCVS and clinical management with Dr. Andy Southerland and his patient, Martien Halvorson-Taylor, in the second part of our four-part series on thunderclap headache.

Disclosures can be found at Neurology.org.

CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.

In the first segment, Dr. Jon Stone talks with Dr. Anne Sofie Hansen about the spectrum and risk of psychiatric disorders in childhood-onset psychogenic nonepileptic seizures. In the second part of the podcast, Dr. Teshamae Monteith discusses ten causes of thunderclap headache and presentation with Dr. Alexandra Cocores in the first part of our four-part series on thunderclap headache.

Disclosures can be found at Neurology.org.

CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.

This month’s replay of past episodes showcases a selection of interviews concerning the FDA approval of aducanumab for the treatment of Alzheimer disease from clinical, political, and economic perspectives. The selected interviews feature conversations between Dr. Gregg Day and Pam Belluck, Dr. Jeff Burns and Dr. Ron Peterson, Dr. Jason Crowell and Dr. Steve Pearson, and Dr. Jeff Burns and Dr. Daniel Gibbs.

Dr. Stacey Clardy discusses the impact of surgical approaches to thymectomy upon remission rates in myasthenia gravis with Dr. Joseph Shrager.

In the first segment, Will Rondeau discusses the symptoms, incidence, and resource utilization of reversible cerebrovascular vasoconstriction syndrome with Dr. Jessica Magid-Bernstein. In the second part of the podcast, Dr. Andy Southerland discusses the optimization of atrial fibrillation treatment and stroke prevention with Dr. Seemant Chaturvedi.

In the first segment, Dr. Alex Menze talks with Dr. Clifford Saper about Havana Syndrome and recent attacks on American diplomats. In the second part of the podcast, Dr. Jeff Ratliff discusses the natural history of afferent baroreflex failure with Dr. Guillaume Lamotte.

In the first segment, Dr. Gregg Day speaks with Dr. Josep Dalmau about NMDAR antibodies in patients with first episode psychosis and the utility of criteria for autoimmune psychosis. In the second part of the podcast, Dr. Jeff Burns talks to neurologist Dr. Daniel Gibbs about his Alzheimer’s disease diagnosis and experience participating in a clinical trial for aducanumab.